Technical Analysis for GH - Guardant Health, Inc.

Grade Last Price % Change Price Change
grade C 70.51 -3.03% -2.20
GH closed down 3.03 percent on Thursday, April 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Down
See historical GH trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Multiple of Ten Bullish Other 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish -3.03%
Hammer Candlestick Bullish -3.03%
Multiple of Ten Bullish Other -3.03%
Gapped Down Weakness -3.03%
Crossed Above 20 DMA Bullish -7.97%
Narrow Range Bar Range Contraction -7.97%
NR7 Range Contraction -7.97%

Older signals for GH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2, respectively. Since its launch in 2014, Guardant360 has been used by more than 5,000 oncologists, over 40 biopharmaceutical companies and all 27 of the National Comprehensive Cancer Network centers.
Medicine Biopharmaceutical Cancer Medical Specialties Disease Oncology
Is GH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 106.58
52 Week Low 27.04
Average Volume 1,290,949
200-Day Moving Average 0.0
50-Day Moving Average 67.6206
20-Day Moving Average 72.626
10-Day Moving Average 71.981
Average True Range 5.6206
ADX 18.45
+DI 23.0577
-DI 28.0368
Chandelier Exit (Long, 3 ATRs ) 74.37819999999999
Chandelier Exit (Short, 3 ATRs ) 78.5518
Upper Bollinger Band 80.4157
Lower Bollinger Band 64.8363
Percent B (%b) 0.36
BandWidth 21.451546
MACD Line 0.6713
MACD Signal Line 1.2
MACD Histogram -0.5287
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 77.40
Resistance 3 (R3) 77.34 75.00 76.25
Resistance 2 (R2) 75.00 73.24 75.02 75.86
Resistance 1 (R1) 72.75 72.16 71.58 72.81 75.48
Pivot Point 70.41 70.41 69.82 70.43 70.41
Support 1 (S1) 68.16 68.65 66.99 68.22 65.54
Support 2 (S2) 65.82 67.57 65.84 65.16
Support 3 (S3) 63.57 65.82 64.77
Support 4 (S4) 63.63